bf/NASDAQ:APLS_icon.jpeg

COM:APELLIS

Apellis Pharmaceuticals, Inc.

  • Stock

USD

Last Close

27.75

22/11 21:00

Market Cap

4.54B

Beta: -

Volume Today

2.66M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.26
-
0.08
71.07%
0.10
31.43%
0.50
406.82%
cash conversion cycle
-123.52
-
11.67
109.45%
3.17K
27,063.68%
849.79
73.19%
cash per share
0.26
-
0.75
186.30%
1.99
164.29%
1.37
30.94%
12.66
821.45%
3.24
74.41%
5.66
74.55%
11.68
106.44%
8.30
28.93%
7.34
11.53%
2.97
59.56%
company equity multiplier
1.15
-
1.08
5.91%
1.09
0.90%
1.15
5.63%
1.22
6.06%
1.26
3.40%
11.37
799.37%
4.70
58.71%
4.44
5.48%
4.48
0.83%
4.05
9.40%
days of inventory outstanding
1.14K
-
5.55K
385.59%
887.20
84.02%
days of payables outstanding
26.34
-
29.26
11.09%
10.60
63.79%
123.52
1,065.78%
1.19K
860.90%
2.42K
103.76%
227.41
90.60%
days of sales outstanding
55.40
-
37.39
32.50%
190.00
408.09%
dividend yield
ebit per revenue
-0.85
-
-8.06
844.84%
-7.88
2.15%
-1.30
83.46%
ebt per ebit
0.98
-
0.99
1.15%
1.00
0.43%
0.99
0.46%
1.00
1.06%
1.00
0.80%
1.06
6.15%
1.60
51.71%
1.39
13.33%
1.10
21.24%
1.02
7.08%
effective tax rate
0.04
-
0.57
1,345.31%
-0.00
-
0.00
185.13%
-0.02
500.87%
-0.01
67.92%
-0.00
91.23%
-0.00
117.62%
-0.00
294.35%
enterprise value multiple
-61.91
-
-21.28
65.63%
34.04
259.97%
-8.39
124.65%
-3.00
64.27%
-4.54
51.50%
-6.05
33.11%
-19.63
224.61%
-6.68
65.96%
-5.90
11.73%
-13.31
125.74%
fixed asset turnover
10.22
-
2.55
75.03%
3.03
18.69%
18.80
520.70%
free cash flow per share
-0.19
-
-0.55
189.34%
-1.04
89.19%
-1.44
37.90%
-3.36
133.73%
-2.41
28.18%
-3.42
41.75%
-2.21
35.46%
-6.68
202.79%
-6.86
2.57%
-5.02
26.80%
gross profit margin
0.90
-
0.92
2.42%
0.93
0.37%
0.85
8.33%
interest coverage
523.83
-
-50.91
109.72%
-54.50
7.06%
-7.14
86.90%
-40.50
467.31%
-18.23
55.00%
-17.48
4.08%
inventory turnover
0.32
-
0.07
79.41%
0.41
525.68%
long term debt to capitalization
0.15
-
0.14
9.52%
0.82
501.08%
0.65
21.02%
0.51
21.23%
0.39
24.07%
0.32
16.33%
net income per ebt
1
-
0.96
3.95%
1
4.11%
1
0%
1
0%
1
0%
1.02
1.68%
1.01
1.12%
1.00
0.49%
1.00
0.06%
1.00
0.30%
net profit margin
-1.38
-
-11.21
714.91%
-8.65
22.88%
-1.33
84.59%
operating cash flow per share
-0.19
-
-0.55
188.76%
-1.04
89.57%
-1.44
37.90%
-3.36
133.73%
-2.41
28.18%
-3.39
40.63%
-2.14
37.07%
-6.67
212.40%
-6.84
2.47%
-5.01
26.68%
operating cycle
1.20K
-
5.59K
366.26%
1.08K
80.72%
operating profit margin
-0.85
-
-8.06
844.84%
-7.88
2.15%
-1.30
83.46%
payables turnover
13.86
-
12.47
9.99%
34.45
176.16%
2.96
91.42%
0.31
89.59%
0.15
50.92%
1.61
963.43%
pretax profit margin
-1.37
-
-11.21
718.91%
-8.64
22.93%
-1.33
84.63%
price fair value
56.13
-
19.19
65.80%
7.26
62.19%
10.67
47.00%
2.02
81.06%
4.46
120.55%
55.67
1,148.92%
21.02
62.24%
20.09
4.41%
22.88
13.88%
36.52
59.62%
receivables turnover
6.59
-
9.76
48.15%
1.92
80.32%
return on assets
-0.76
-
-0.75
1.02%
-1.22
61.57%
-0.99
18.85%
-0.28
71.68%
-0.63
123.69%
-0.80
27.06%
-0.36
54.89%
-0.85
135.75%
-0.86
1.35%
-0.67
21.87%
return on capital employed
-0.89
-
-0.85
4.15%
-1.33
55.91%
-1.15
13.89%
-0.29
74.78%
-0.69
137.21%
-0.89
29.81%
-0.26
71.16%
-0.72
178.46%
-1.00
40.31%
-0.96
4.76%
return on equity
-0.88
-
-0.82
6.87%
-1.33
63.02%
-1.14
14.28%
-0.34
69.96%
-0.79
131.29%
-9.05
1,042.71%
-1.69
81.37%
-3.76
122.84%
-3.84
2.19%
-2.72
29.21%
total debt to capitalization
0.15
-
0.14
4.44%
0.82
470.80%
0.65
20.99%
0.51
20.74%
0.40
22.42%
0.34
15.17%

All numbers in USD (except ratios and percentages)